Magenta Medical Inc. Company Profile

14:44 EST 18th January 2019 | BioPortfolio

News Articles [129 Associated News Articles listed on BioPortfolio]

Jason Ryan of Foundation Medicine Joins Magenta’s C-Suite

Magenta Therapeutics (NASDAQ: MGTA) has appointed Jason Ryan to serve as chief operating and financial officer, effective Jan. 1. Ryan is joining Cambridge, MA-based Magenta from Foundation Medicine, ...

STAT Plus: Magenta’s stem cell expansion therapy reveals hope and concern in first data look

By expanding the number of stem cells in each cord blood unit, Magenta aims to give more patients a chance at a successful transplant.

Magenta Therapeutics to Present at Wedbush PacGrow Healthcare Conference

Magenta Therapeutics (NASDAQ: MGTA), a clinical-stage biotechnology company developing novel medicines to bring the curative power of bone marrow transplant to more patient...

Magenta Therapeutics to Host Webcast of Investor and Analyst Event During ASH

Magenta Therapeutics (NASDAQ: MGTA), a clinical-stage biotechnology company developing novel medicines to bring the curative power of bone marrow transplant to more patient...

Magenta Therapeutics to Present at the 37th Annual J.P. Morgan Healthcare Conference on Wednesday, January 9, 2019

Magenta Therapeutics (NASDAQ: MGTA), a clinical-stage biotechnology company developing novel medicines to bring the curative power of bone marrow transplant to more patient...

Magenta Therapeutics: This June IPO Should Be On Your Radar

Heidelberg Pharma inks US$334m R&D contract with Magenta Therapeutics

Magenta Therapeutics: Developing Novel Treatments In Hematopoietic Stem Cell Transplants

Drugs and Medications [0 Results]


PubMed Articles [1747 Associated PubMed Articles listed on BioPortfolio]

Prevalence and correlates of non-medical only compared to self-defined medical and non-medical cannabis use, Canada, 2015.

The Canadian federal government has committed to legalizing non-medical cannabis use by adults in 2018. Medical use was legalized in 2001; however, not all people reporting medical use have medical au...

Medical and non-medical marijuana use in depression: Longitudinal associations with suicidal ideation, everyday functioning, and psychiatry service utilization.

Marijuana use is clinically problematic in depression, and non-medical and medical use may both contribute to barriers to care in this population. Among outpatients with depression, we examined the di...

Insights into medical humanities education in China and the West.

Medical humanity is the soul of health education. Beginning medical students are taught various aspects of basic medicine, such as biochemistry, anatomy, and immunology. However, cultivation of the hu...

Automated sequential chromogenic IHC double staining with two HRP substrates.

Automated IHC double staining using diaminobenzidine and HRP Magenta is illustrated utilizing a new acidic block with sulfuric acid to prevent cross-reactivity. Residual cross-reactivity in double sta...

Should parents see their teen's medical record? Asking about the effect on adolescent-doctor communication changes attitudes.

Parents routinely access young children's medical records, but medical societies strongly recommend confidential care during adolescence, and most medical centers restrict parental records access duri...

Clinical Trials [1766 Associated Clinical Trials listed on BioPortfolio]

Stand up to Cancer: MAGENTA (Making Genetic Testing Accessible)

The goal of this research study is to test the effects of online genetic education alone or in combination with telephone genetic counseling in order to compare the two methods and the str...

A 24-52-Week Study to Evaluate the Long-Term Efficacy and Safety of Saredutant in Patients With Depression (MAGENTA)

The purpose of the study is to evaluate the long-term efficacy and safety of saredutant in patients with depression. The primary objective is to evaluate the efficacy and safety of saredut...

Doctor-Parent Interactions With Medical Scribes

The purpose of the study is to collect outcomes related to a quality improvement project assessing the feasibility and effectiveness of a medical scribe program in which medical scribes ac...

Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation

PCI (optimal catheter-based coronary revascularization) + intensive medical therapy is superior to intensive medical therapy alone using the combined endpoint of all-cause mortality or non...

Chart Review Study of Medical Abortion

The primary objective of this study is to document the rates of success and serious complications among women having outpatient medical abortions with 200 mg mifepristone + 800 buccal miso...

Companies [1220 Associated Companies listed on BioPortfolio]

Magenta Therapeutics

Magenta Therapeutics is a biotechnology company harnessing the power of stem cell science to revolutionize stem cell transplantation for patients with immune- and blood-based dise...

Magenta Therapeutics Inc.

Magenta Therapeutics is a biotechnology company developing therapeutics to revolutionize bone marrow transplant for patients with autoimmune diseases, blood cancers and genetic di...

Magenta Medical Inc.

Magenta Therapeutics, Inc.

Chemence Medical, Inc.

Chemence Medical, Inc., headquartered in metropolitan Atlanta, GA, has redefined the medical adhesives industry, and has become a world leader in the medical device arena since it...

More Information about "Magenta Medical Inc." on BioPortfolio

We have published hundreds of Magenta Medical Inc. news stories on BioPortfolio along with dozens of Magenta Medical Inc. Clinical Trials and PubMed Articles about Magenta Medical Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Magenta Medical Inc. Companies in our database. You can also find out about relevant Magenta Medical Inc. Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record